comprehensive -WSS

comprehensive

author：entertainment 2025-09-03 03:17:38 - browse：1

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Beach reads and more: STAT's 2023 summer book list

focus

WSS

Clinical trials giant ICON acquires HumanFirst

Flu vaccine offering decent levels of protection this winter, new data show

In search for therapies for solid tumors, companies turn to claudin

Biden launches a new push to limit health care costs

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Retired US general questions alleged Putin, Prigozhin meeting

knowledge

comprehensive

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Leqembi, other new Alzheimer’s drugs require better biomarkers

Cancer drug shortages should be causing more outrage

ALS groups 'won't be played again' by the FDA, drug sponsors

How to save PrEP access — and even expand it

Living with Fabry disease, a condition that causes chronic pain

At least 13 dead in Texas as scorching temps continue

FDA does about

Cancer drug shortages should be causing more outrage

Biotech companies concerned about China biosecurity crackdown

Wikipedia

In search for therapies for solid tumors, companies turn to claudin

How to fix the rural physician shortage in the U.S.

Change Healthcare cyberattack outage could last weeks

Obesity now affects over 1 billion people worldwide, study finds

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

focus

hotspot

focus

leisure time